Overview
- Active ingredient
- Phenazopyridine Hydrochloride
- Route
- Oral
- Label date
- 2025-03-28
Indications and usage
Uses Prompt temporary relief of: pain during urination burning sensation of urgency increased frequency associated with urinary tract infections.
Purpose
Urinary Analgesic
Dosage and administration
Directions Read all package directions and warnings before use. Use only as directed. Do not exceed recommended dosage. Adults: Swallow two (2) tablets with water after meals as needed up to 3 times daily for 2 days maximum. Swallow whole. Do not crush or chew. Do not use more than 12 tablets in 2 days. Drink 6 to 8 eight glasses of water daily. For use by normally healthy adults only. Persons under 18 years of age should use only as directed by a doctor.
Do not use
if you have liver or kidney problems allergies to foods, preservatives or dyes had a hypersensitive reaction to phenazopyridine hydrochloride.
Ask a doctor or pharmacist before use if
Ask a doctor or pharmacist before use if you are taking any other medications.
When using this product
this product stomach upset may occur; taking this product with or after meals may reduce stomach upset you may experience a reddish-orange discoloration of the urine which is a non-harmful temporary effect.
Stop use and ask a doctor if
and ask a doctor if your symptoms do not go away after two days or become worse you experience fever, chills, back pain or bloody urine you suspect you are having an adverse reaction to this medication.
Pregnancy or breast-feeding
If pregnant or breastfeeding, ask a health professional before use.
Information for patients
Other information WARNING: this product contains a chemical known to the State of California to cause cancer. Precaution: Carcinogenesis: Long-term administration of phenazopyridine HCl has induced neoplasia in rats (large intestine) and mice (liver) . Although no association between phenazopyridine HCl and human neoplasia has been reported, adequate epidemiological studies along these lines have not been conducted. **Contents sealed: Each URICALM dark red colored, round shaped tablet bears the identifying mark "ALVA" and a "1" on the reverse side, and is sealed in a clear plastic blister with with foil backing. Do not use if seal appears broken or if product contents do not match product description. This product may stain soft contact lenses. This product can interfere with laboratory tests including urine, glucose (sugar) and ketones. You may report serious side effects to the phone number provided under Questions? below.
Active ingredient (label)
(in each tablet) Phenazopyridine hydrochloride, 99.5 mg
Inactive ingredients
s Carmine, Citric Acid, Cornstarch, Cranberry Extract, Croscarmellose Sodium, FD&C Red No. 40, FD&C Red No. 40 Lake, FD&C Yellow No. 6 Lake, Hypromellose, Magnesium Stearate, Maltodextrin, Microcrystalline Cellulose, Mineral Oil, Polyethylene Glycol, Polyvinylpyrrolidone, Pregelatinized Starch, Silicon Dioxide, Talc, Titanium Dioxide and Triacetin.
Keep out of reach of children
of children. In case of overdose, get medical help or contact a poison control center right away.